Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 994 | 250 | 865 | 1,194 | 1,064 |
| Receivables | 88 | 65 | 80 | 22 | 11 |
| Other current assets | 0 | 373 | 294 | 111 | 93 |
| TOTAL | $2,437 | $744 | $1,261 | $1,358 | $1,265 |
| Non-Current Assets | |||||
| PPE Net | 0 | 15 | 37 | 60 | 83 |
| Intangibles | 2,547 | 186 | 185 | 194 | 195 |
| Other Non-Current Assets | 1,200 | 1,200 | 1,200 | 1,200 | 1,200 |
| TOTAL | $3,747 | $1,400 | $1,422 | $1,454 | $1,478 |
| Total Assets | $6,184 | $2,145 | $2,684 | $2,811 | $2,742 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 679 | 845 | 554 | 677 | 454 |
| Other current liabilities | 1 | 1 | 8 | 101 | 177 |
| TOTAL | $680 | $861 | $599 | $837 | $712 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $680 | $861 | $599 | $837 | $712 |
| Shareholders' Equity | |||||
| Common Shares | 20,804 | 20,184 | 20,184 | 19,489 | 18,913 |
| Retained earnings | -26,324 | -24,633 | -23,825 | -23,234 | -22,585 |
| Other shareholders' equity | 11,025 | 5,733 | 5,726 | 5,719 | 5,703 |
| TOTAL | $5,505 | $1,284 | $2,085 | $1,974 | $2,031 |
| Total Liabilities And Equity | $6,184 | $2,145 | $2,684 | $2,811 | $2,742 |